policies >  DOI:10.25504/FAIRsharing.7KZpOx

ready Policy for IDG Consortium Interaction with Other Entities (Consortia/Institutes /Associations/Biotech/Pharma)


General Information

Homepage https://druggablegenome.net/IDGPolicies#Policy7

Countries that developed this resource Denmark , United Kingdom , United States

Published in 2018

Type: Project

Description:

IDG members are encouraged to foster collaborations and interactions with individual laboratories/researchers, consortia, associations, pharma, and biotech, as well as other outside entities. The guidelines outlined here are to enhance these interactions for the benefit of sharing IDG outcomes.

Collections/recommendations derived from this policy:


Taxonomic range


Knowledge Domains


How to cite this record FAIRsharing.org: Policy for IDG Consortium Interaction with Other Entities (Consortia/Institutes /Associations/Biotech/Pharma); DOI: https://doi.org/10.25504/FAIRsharing.7KZpOx; Last edited: Dec. 19, 2019, 11:07 a.m.; Last accessed: Sep 30 2020 11:36 p.m.


This record is maintained by dvidovic  ORCID

Record added: Oct. 3, 2019, 4:10 p.m. Record updated: Nov. 4, 2019, 11:31 a.m. by The FAIRsharing Team.
Show edit history


Organisations

Record Maintainer

Funds

  • NIH (Government body)

Maintains


Policy External Cross References

TOP Level Data Transparency: Not available

TOP qualifying comments: Not available


Standards and Databases mentioned in this policy

Databases

No Databases Listed

Standards

No Standards Listed


Usage / Access

Conditions of Use




Support

No support information provided.

Additional Information